Plate Nº 75 · recorded October 10, 2026
Health & Medicine ResearchReported finding
Menstrual Tracking Apps Lack Evidence, BMJ Experts Warn
BMJ researchers argue menstrual tracking apps and cycle syncing lack scientific backing and may harm women's health through wasted time, surveillance and data privacy threats.
By James Calloway3 min read574 words
In brief
- BMJ analysis concludes digital menstrual tracking apps risk causing more harm than benefit
- Authors led by Katharine Lee published the critique, DOI 10.1136/bmj-2026-100858
- Decades of sports science research show no overall effect of menstrual cycle phase on performance, injury risk or health
- Authors identify four main risks: wasted time, surveillance, data privacy threats, and distraction from advancing women's health
- Authors propose a four-part agenda covering data protections, user awareness, clinician standards, and marketing regulation
Menstrual tracking apps and the practice of "cycle syncing" risk causing more harm than benefit, according to a new analysis in The BMJ.
Researchers led by Katharine Lee published a sharp critique of consumer "femtech" tools that promise to scientifically analyze personal data and tailor diet, exercise and well-being advice to the phases of a user's cycle. Tech firms and social media influencers promote the apps widely to women and girls.
What do the experts actually argue?
Lee and her colleagues reviewed the research and identified two big gaps. No convincing studies show that menstrual tracking improves health or performance. The practice of cycle syncing — changing food and workouts to match cycle phases — rests on similarly thin evidence, despite its popularity on lifestyle platforms.
Decades of sports science research show no overall effect of menstrual cycle phase on athletic performance, injury risk or general health, the authors write. Any effects found have been trivial and highly individualized.
Research on phase-based dietary interventions remains generally inconclusive, highly individualized or speculative.
Why do the risks matter?
Even if hormones did shift performance day to day, a phone app cannot reliably predict those changes, the authors explain. The tools also create several second-order harms:
- Wasted time and effort spent tracking data
- Unwanted data collection and surveillance
- Threats to health data privacy
- A distraction from genuine efforts to advance women's health
The slick marketing of cycle tracking apps and the scientifically suspect practice of cycle syncing "require critical interrogation and resistance," the authors write.
"These apps have the potential for widespread impact on the well-being of women and girls," they warn. "Yet, the evidence that these digital tools can actually help in the management of menstrual conditions, boost health, and provide insights into exercise and nutritional needs is lacking."
What do regulators and clinicians need to do?
The team offers a four-part agenda:
- Strengthen legal protections for consumer and employee health data
- Improve user awareness of how cycle data get used
- Tell clinicians to recommend apps only when they meet stringent scientific and ethical tests
- Regulate misleading marketing that co-opts feminist language to sell unproven products
Public health campaigns should tailor messages to the social media environments where users encounter cycle syncing content, the authors note. Meeting women on the same platforms that spread the hype offers a chance to rebuild trust in credible sources.
Others, the authors add, have called for tighter regulation of misleading marketing and resistance to the commercial co-option of feminist activist rhetoric by app makers.
Health practitioners, regulators and the public must recognize and address the risks these consumer technologies pose to women's health, the authors conclude.
How strong is the evidence?
Lee and her colleagues frame their work as an analysis of existing research, not a new clinical trial. Their conclusions rest on a reading of published studies rather than fresh data collection.
The piece fits the BMJ's tradition of publishing opinion-style analyses alongside original research. As with any commentary, the claims depend on how the authors selected and weighed prior studies, not on new experiments.
The analysis sides with critics who doubt cycle syncing's benefits. It does not close the debate, since proponents continue to argue that individual variation matters more than group averages.
Readers should treat the warnings as a call for more rigorous study of what these apps actually deliver, rather than as a final verdict.
via Medical Xpress (Source)
More from James Calloway
Show full bio
Staff writer covering marketplaces and e-commerce at SciBeat.
205 articles
Nearby plates
- Medical Records Barely Track Menopause, Study of 240,000 Women Finds
- More Daily Steps Linked to Fewer Teen Mental Health Problems
- FDA Highlights Digital Health Technologies for Drug Development
- Exercise Program Boosts Attention and May Slow Aging in Breast Cancer Survivors
- ATTAIN-MAINTAIN Trial Tests Orforglipron for Sustained Weight Loss